JP2021500409A5 - - Google Patents

Info

Publication number

JP2021500409A5

JP2021500409A5 JP2020543474A JP2020543474A JP2021500409A5 JP 2021500409 A5 JP2021500409 A5 JP 2021500409A5 JP 2020543474 A JP2020543474 A JP 2020543474A JP 2020543474 A JP2020543474 A JP 2020543474A JP 2021500409 A5 JP2021500409 A5 JP 2021500409A5

Authority

JP

Japan

Prior art keywords

composition

peptide

combination

use according

splice

Prior art date

2018-10-23

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108090000765 processed proteins & peptides Proteins 0.000 claims description 105
• 239000000203 mixture Substances 0.000 claims description 87
• 101000666295 Homo sapiens X-box-binding protein 1 Proteins 0.000 claims description 50
• 102100038151 X-box-binding protein 1 Human genes 0.000 claims description 50
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 33
• 102100035721 Syndecan-1 Human genes 0.000 claims description 21
• 102100032831 Protein ITPRID2 Human genes 0.000 claims description 20
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 20
• 101710178046 Chorismate synthase 1 Proteins 0.000 claims description 18
• 101710152695 Cysteine synthase 1 Proteins 0.000 claims description 18
• 150000001413 amino acids Chemical class 0.000 claims description 16
• 208000003721 Triple Negative Breast Neoplasms Diseases 0.000 claims description 15
• 208000022679 triple-negative breast carcinoma Diseases 0.000 claims description 15
• 206010006187 Breast cancer Diseases 0.000 claims description 14
• 208000026310 Breast neoplasm Diseases 0.000 claims description 14
• 239000002671 adjuvant Substances 0.000 claims description 11
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 8
• 229960002621 pembrolizumab Drugs 0.000 claims description 8
• 230000028993 immune response Effects 0.000 claims description 7
• 239000002246 antineoplastic agent Substances 0.000 claims description 6
• 229940127089 cytotoxic agent Drugs 0.000 claims description 6
• 230000003308 immunostimulating effect Effects 0.000 claims description 5
• 229940076838 Immune checkpoint inhibitor Drugs 0.000 claims description 4
• 102000037984 Inhibitory immune checkpoint proteins Human genes 0.000 claims description 4
• 108091008026 Inhibitory immune checkpoint proteins Proteins 0.000 claims description 4
• 206010028980 Neoplasm Diseases 0.000 claims description 4
• 239000002253 acid Substances 0.000 claims description 4
• 201000011510 cancer Diseases 0.000 claims description 4
• 239000012274 immune-checkpoint protein inhibitor Substances 0.000 claims description 4
• 229960001438 immunostimulant agent Drugs 0.000 claims description 4
• 239000003022 immunostimulating agent Substances 0.000 claims description 4
• 230000001939 inductive effect Effects 0.000 claims description 3
• 238000011282 treatment Methods 0.000 claims description 3
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 2
• 102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 2
• 206010055113 Breast cancer metastatic Diseases 0.000 claims description 2
• 101100463133 Caenorhabditis elegans pdl-1 gene Proteins 0.000 claims description 2
• 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
• 108090000695 Cytokines Proteins 0.000 claims description 2
• 102000004127 Cytokines Human genes 0.000 claims description 2
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 claims description 2
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 2
• 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 claims description 2
• 101000746367 Homo sapiens Granulocyte colony-stimulating factor Proteins 0.000 claims description 2
• 102000037982 Immune checkpoint proteins Human genes 0.000 claims description 2
• 108091008036 Immune checkpoint proteins Proteins 0.000 claims description 2
• 102100040678 Programmed cell death protein 1 Human genes 0.000 claims description 2
• 101710089372 Programmed cell death protein 1 Proteins 0.000 claims description 2
• 229940022399 cancer vaccine Drugs 0.000 claims description 2
• 238000009566 cancer vaccine Methods 0.000 claims description 2
• 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
• 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
• 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
• 239000000839 emulsion Substances 0.000 claims description 2
• 229940126546 immune checkpoint molecule Drugs 0.000 claims description 2
• 239000002955 immunomodulating agent Substances 0.000 claims description 2
• 230000005865 ionizing radiation Effects 0.000 claims description 2
• 229960005386 ipilimumab Drugs 0.000 claims description 2
• 230000001394 metastastic effect Effects 0.000 claims description 2
• 206010061289 metastatic neoplasm Diseases 0.000 claims description 2
• 108700002563 poly ICLC Proteins 0.000 claims description 2
• 229920000729 poly(L-lysine) polymer Polymers 0.000 claims description 2
• 102000004169 proteins and genes Human genes 0.000 claims description 2
• 108090000623 proteins and genes Proteins 0.000 claims description 2
• 150000003384 small molecules Chemical class 0.000 claims description 2
• 229950007217 tremelimumab Drugs 0.000 claims description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
• 239000003814 drug Substances 0.000 claims 12
• 239000003795 chemical substances by application Substances 0.000 claims 2
• 239000013066 combination product Substances 0.000 claims 2
• 229940127555 combination product Drugs 0.000 claims 2
• 229940079593 drug Drugs 0.000 claims 2
• 238000004519 manufacturing process Methods 0.000 claims 2
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 2
• 229930012538 Paclitaxel Natural products 0.000 claims 1
• 229940123237 Taxane Drugs 0.000 claims 1
• 230000000340 anti-metabolite Effects 0.000 claims 1
• 229940100197 antimetabolite Drugs 0.000 claims 1
• 239000002256 antimetabolite Substances 0.000 claims 1
• 210000000481 breast Anatomy 0.000 claims 1
• 229960004562 carboplatin Drugs 0.000 claims 1
• 190000008236 carboplatin Chemical compound 0.000 claims 1
• 229960005277 gemcitabine Drugs 0.000 claims 1
• SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims 1
• 229960001592 paclitaxel Drugs 0.000 claims 1
• 229910052697 platinum Inorganic materials 0.000 claims 1
• DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims 1
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 1
• 238000000034 method Methods 0.000 description 37
• 238000012986 modification Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1